Michael J Hall

17PUBLICATIONS
110CO-AUTHORS
Cancer geneticsMedical molecular engineering of nucleic acids and proteinsMedical mycologyPredictive and prognostic markersFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 02, 2026
Redefining the EPCAM Phenotype: Deletion Architecture Determines Lynch Syndrome Cancer Risk.

|Jan 31, 2026
A history of the collaborative group of the Americas on inherited gastrointestinal cancer (CGA-IGC): 1995-2025.

Beth Dudley, Bruce M Boman, Marc S Greenblatt

|Jan 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial.

Anna Morena D'Alise, Jason Willis, Fahriye Duzagac

|Oct 16, 2025
Risks and Implications of Multiple Actionable Pathogenic Germline Variants Discovered by Panel-Based Cancer Predisposition Testing.

Catherine Neumann, Demitrios Dedousis, Michael J Hall

|Feb 26, 2025
Prevalence and Predictors of Medical Mistrust Among Socioeconomically and Racially Diverse Cancer Patients in Philadelphia.

Michael J Hall, Cindy Y Park, Karen J Ruth

|Nov 15, 2024
Uptake of Aspirin Chemoprevention in Patients With Lynch Syndrome.

Sachi Singhal, Emma D Riggs, Karen J Ruth

Pageof 3

Frequent Collaborators

3 joint publications

Joanne Xiu

2 joint publications

Heinz-Josef Lenz

2 joint publications

Andreas Seeber

2 joint publications

John Marshall